Published in J Clin Microbiol on February 17, 2010
Utility of matrix-assisted laser desorption ionization-time of flight mass spectrometry following introduction for routine laboratory bacterial identification. J Clin Microbiol (2011) 2.73
Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology. Clin Microbiol Rev (2013) 2.34
Clinical evaluation of the FilmArray blood culture identification panel in identification of bacteria and yeasts from positive blood culture bottles. J Clin Microbiol (2013) 2.11
Use of PCR coupled with electrospray ionization mass spectrometry for rapid identification of bacterial and yeast bloodstream pathogens from blood culture bottles. J Clin Microbiol (2010) 2.06
Direct matrix-assisted laser desorption ionization time-of-flight mass spectrometry improves appropriateness of antibiotic treatment of bacteremia. PLoS One (2012) 1.84
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry identification of mycobacteria in routine clinical practice. PLoS One (2011) 1.77
Identification of bacteria in blood culture broths using matrix-assisted laser desorption-ionization Sepsityper™ and time of flight mass spectrometry. PLoS One (2011) 1.42
Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care (2011) 1.35
Bacteremia caused by Comamonas kerstersii in a patient with diverticulosis. J Clin Microbiol (2013) 1.26
MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis. Front Microbiol (2015) 1.26
Novel, improved sample preparation for rapid, direct identification from positive blood cultures using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. J Mol Diagn (2011) 1.25
Improved identification of yeast species directly from positive blood culture media by combining Sepsityper specimen processing and Microflex analysis with the matrix-assisted laser desorption ionization Biotyper system. J Clin Microbiol (2011) 1.22
Rapid identification of bacteria and yeasts from positive-blood-culture bottles by using a lysis-filtration method and matrix-assisted laser desorption ionization-time of flight mass spectrum analysis with the SARAMIS database. J Clin Microbiol (2012) 1.21
Identification of Brucella by MALDI-TOF mass spectrometry. Fast and reliable identification from agar plates and blood cultures. PLoS One (2010) 1.20
An evaluation of three processing methods and the effect of reduced culture times for faster direct identification of pathogens from BacT/ALERT blood cultures by MALDI-TOF MS. Eur J Clin Microbiol Infect Dis (2011) 1.19
Rapid identification of bacteria in positive blood culture by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Eur J Clin Microbiol Infect Dis (2011) 1.18
Comparison of an in-house method and the commercial Sepsityper™ kit for bacterial identification directly from positive blood culture broths by matrix-assisted laser desorption-ionisation time-of-flight mass spectrometry. Eur J Clin Microbiol Infect Dis (2012) 1.16
Rapid identification of Cryptococcus neoformans and Cryptococcus gattii by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2011) 1.15
Current approaches to the diagnosis of bacterial and fungal bloodstream infections in the intensive care unit. Crit Care Med (2012) 1.12
A comparative study of two different methods of sample preparation for positive blood cultures for the rapid identification of bacteria using MALDI-TOF MS. Eur J Clin Microbiol Infect Dis (2011) 1.10
Direct identification of bacteria from charcoal-containing blood culture bottles using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry. Eur J Clin Microbiol Infect Dis (2012) 1.06
Rapid Identification of microbes in positive blood cultures by use of the vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system. J Clin Microbiol (2013) 1.05
What is new in clinical microbiology-microbial identification by MALDI-TOF mass spectrometry: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J Mol Diagn (2012) 1.02
Evaluation of species-specific score cutoff values of routinely isolated clinically relevant bacteria using a direct smear preparation for matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based bacterial identification. Eur J Clin Microbiol Infect Dis (2011) 0.96
Direct analysis and identification of pathogenic Lichtheimia species by matrix-assisted laser desorption ionization-time of flight analyzer-mediated mass spectrometry. J Clin Microbiol (2011) 0.94
Rapid identification of pathogens in positive blood culture of patients with sepsis: review and meta-analysis of the performance of the sepsityper kit. Int J Microbiol (2015) 0.94
Saponin promotes rapid identification and antimicrobial susceptibility profiling of Gram-positive and Gram-negative bacteria in blood cultures with the Vitek 2 system. Eur J Clin Microbiol Infect Dis (2012) 0.93
Developments for improved diagnosis of bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis (2014) 0.90
Promising new assays and technologies for the diagnosis and management of infectious diseases. Clin Infect Dis (2012) 0.90
Cryptococcus neoformans meningitis with negative cryptococcal antigen: Evaluation of a new immunochromatographic detection assay. New Microbes New Infect (2014) 0.90
In situ identification of plant-invasive bacteria with MALDI-TOF mass spectrometry. PLoS One (2012) 0.89
Rapid intrinsic fluorescence method for direct identification of pathogens in blood cultures. MBio (2013) 0.88
Comparative evaluation of Vitek 2 identification and susceptibility testing of Gram-negative rods directly and isolated from BacT/ALERT-positive blood culture bottles. Eur J Clin Microbiol Infect Dis (2011) 0.84
A differential centrifugation protocol and validation criterion for enhancing mass spectrometry (MALDI-TOF) results in microbial identification using blood culture growth bottles. Eur J Clin Microbiol Infect Dis (2012) 0.83
Development of a rapid and simplified protocol for direct bacterial identification from positive blood cultures by using matrix assisted laser desorption ionization time-of- flight mass spectrometry. BMC Microbiol (2015) 0.80
Direct Identification and Antimicrobial Susceptibility Testing of Bacteria From Positive Blood Culture Bottles by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry and the Vitek 2 System. Ann Lab Med (2016) 0.78
Preparation of a blood culture pellet for rapid bacterial identification and antibiotic susceptibility testing. J Vis Exp (2014) 0.78
Rapid Identification of Bacteria Directly from Positive Blood Cultures by Use of a Serum Separator Tube, Smudge Plate Preparation, and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. J Clin Microbiol (2015) 0.76
Rapid identification of positive blood cultures by matrix-assisted laser desorption ionization-time of flight mass spectrometry using prewarmed agar plates. J Clin Microbiol (2014) 0.75
Early detection of extended-spectrum β-lactamase from blood culture positive for an Enterobacteriaceae using βLACTA test. New Microbes New Infect (2015) 0.75
Identification of pathogens from blood culture bottles in spiked and clinical samples using matrix-assisted laser desorption ionization time-of-flight mass-spectrometry analysis. BMC Res Notes (2014) 0.75
Case report: when two and ½ men go camping…. BMC Infect Dis (2017) 0.75
MALDI-TOF MS Versus VITEK(®)2: Comparison of Systems for the Identification of Microorganisms Responsible for Bacteremia. Curr Microbiol (2016) 0.75
Mass spectrometry and multiplex antigen assays to assess microbial quality and toxin production of Staphylococcus aureus strains isolated from clinical and food samples. Biomed Res Int (2014) 0.75
Evaluation of three sample preparation methods for the direct identification of bacteria in positive blood cultures by MALDI-TOF. BMC Res Notes (2017) 0.75
Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis (2009) 16.51
Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to 16S rRNA gene sequencing for species identification of nonfermenting bacteria. J Clin Microbiol (2008) 4.18
Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J Clin Microbiol (2003) 3.17
Rapid identification of viridans streptococci by mass spectrometric discrimination. J Clin Microbiol (2007) 2.49
Highly efficient classification and identification of human pathogenic bacteria by MALDI-TOF MS. Mol Cell Proteomics (2007) 1.73
Phyloproteomics: species identification of Enterobacteriaceae using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Mol Microbiol Biotechnol (2001) 1.65
Sample preparation of Gram-positive bacteria for identification by matrix assisted laser desorption/ionization time-of-flight. J Microbiol Methods (2002) 1.56
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis (2008) 5.39
Detection of four Plasmodium species in blood from humans by 18S rRNA gene subunit-based and species-specific real-time PCR assays. J Clin Microbiol (2004) 5.23
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J Clin Microbiol (2004) 4.70
Amoebal coculture of "Mycobacterium massiliense" sp. nov. from the sputum of a patient with hemoptoic pneumonia. J Clin Microbiol (2004) 4.32
Gene sequence-based criteria for identification of new rickettsia isolates and description of Rickettsia heilongjiangensis sp. nov. J Clin Microbiol (2003) 3.59
Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis (2004) 3.25
1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis (2008) 3.19
Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol Microbiol (2003) 3.12
Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr (2009) 2.80
TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot Cell (2004) 2.61
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis (2008) 2.55
A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics (2006) 2.54
Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol Rev (2011) 2.43
A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol Microbiol (2002) 2.14
Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections. Clin Infect Dis (2012) 2.11
Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob Agents Chemother (2003) 1.98
β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. Am J Respir Crit Care Med (2013) 1.95
Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc Natl Acad Sci U S A (2006) 1.92
Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Antimicrob Agents Chemother (2004) 1.86
Impact of matrix-assisted laser desorption ionization time-of-flight mass spectrometry on the clinical management of patients with Gram-negative bacteremia: a prospective observational study. Clin Infect Dis (2012) 1.83
Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions. Diagn Microbiol Infect Dis (2003) 1.80
Biodiversity of amoebae and amoeba-resisting bacteria in a hospital water network. Appl Environ Microbiol (2006) 1.80
CRZ1, a target of the calcineurin pathway in Candida albicans. Mol Microbiol (2006) 1.74
High proportion of wrongly identified methicillin-resistant Staphylococcus aureus carriers by use of a rapid commercial PCR assay due to presence of staphylococcal cassette chromosome element lacking the mecA gene. J Clin Microbiol (2010) 1.67
Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. Fungal Genet Biol (2002) 1.66
Genome of Acanthamoeba castellanii highlights extensive lateral gene transfer and early evolution of tyrosine kinase signaling. Genome Biol (2013) 1.62
Pathogenic potential of novel Chlamydiae and diagnostic approaches to infections due to these obligate intracellular bacteria. Clin Microbiol Rev (2006) 1.62
Waddlia chondrophila, a potential agent of human fetal death. Emerg Infect Dis (2007) 1.57
Lausannevirus, a giant amoebal virus encoding histone doublets. Environ Microbiol (2011) 1.53
Emerging role of Chlamydia and Chlamydia-like organisms in adverse pregnancy outcomes. Curr Opin Infect Dis (2008) 1.49
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland. Antimicrob Agents Chemother (2007) 1.49
Diagnosis of Bartonella endocarditis by a real-time nested PCR assay using serum. J Clin Microbiol (2003) 1.38
Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care (2011) 1.35
Parachlamydiaceae as rare agents of pneumonia. Emerg Infect Dis (2003) 1.35
Criblamydia sequanensis, a new intracellular Chlamydiales isolated from Seine river water using amoebal co-culture. Environ Microbiol (2006) 1.34
Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes. Curr Opin Infect Dis (2013) 1.33
PCR detection of bacteria on cardiac valves of patients with treated bacterial endocarditis. J Clin Microbiol (2005) 1.33
Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey. J Clin Microbiol (2003) 1.33
Biodiversity of amoebae and amoebae-resisting bacteria in a drinking water treatment plant. Environ Microbiol (2008) 1.33
Bloodstream and endovascular infections due to Abiotrophia defectiva and Granulicatella species. BMC Infect Dis (2006) 1.31
A novel real-time PCR to detect Chlamydia trachomatis in first-void urine or genital swabs. J Med Microbiol (2006) 1.30
Amoebal pathogens as emerging causal agents of pneumonia. FEMS Microbiol Rev (2009) 1.28
The Waddlia genome: a window into chlamydial biology. PLoS One (2010) 1.27
Bacteremia caused by Comamonas kerstersii in a patient with diverticulosis. J Clin Microbiol (2013) 1.26
Development of a new chlamydiales-specific real-time PCR and its application to respiratory clinical samples. J Clin Microbiol (2011) 1.23
In vitro susceptibility of Actinobaculum schaalii to 12 antimicrobial agents and molecular analysis of fluoroquinolone resistance. J Antimicrob Chemother (2010) 1.22
Analysis of natural variants of the human immunodeficiency virus type 1 gag-pol frameshift stem-loop structure. J Virol (2002) 1.21
Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis. Antimicrob Agents Chemother (2004) 1.21
Amoeba-resisting bacteria and ventilator-associated pneumonia. Emerg Infect Dis (2003) 1.19
Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients. J Infect Dis (2003) 1.15
New diagnostic real-time PCR for specific detection of Parachlamydia acanthamoebae DNA in clinical samples. J Clin Microbiol (2008) 1.14
Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin. Antimicrob Agents Chemother (2010) 1.11
Role of Waddlia chondrophila placental infection in miscarriage. Emerg Infect Dis (2014) 1.09
Novel Chlamydiales strains isolated from a water treatment plant. Environ Microbiol (2008) 1.09
Legionella drancourtii sp. nov., a strictly intracellular amoebal pathogen. Int J Syst Evol Microbiol (2004) 1.09
Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods. Antimicrob Agents Chemother (2006) 1.09
Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay. J Clin Microbiol (2011) 1.08
Parachlamydia spp. and related Chlamydia-like organisms and bovine abortion. Emerg Infect Dis (2007) 1.08
'Candidatus Rhabdochlamydia crassificans', an intracellular bacterial pathogen of the cockroach Blatta orientalis (Insecta: Blattodea). Syst Appl Microbiol (2006) 1.08
Epidemiology of methicillin-resistant Staphylococcus aureus: results of a nation-wide survey in Switzerland. Swiss Med Wkly (2002) 1.08
African tick-bite fever: a new entity in the differential diagnosis of multiple eschars in travelers. Description of five cases imported from South Africa to Switzerland. Int J Infect Dis (2010) 1.07
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program. Diagn Microbiol Infect Dis (2010) 1.06
Role of Chlamydia trachomatis in miscarriage. Emerg Infect Dis (2011) 1.06
Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes. Antimicrob Agents Chemother (2003) 1.06
Comparison of automated strategies for surveillance of nosocomial bacteremia. Infect Control Hosp Epidemiol (2007) 1.05
Protochlamydia naegleriophila as etiologic agent of pneumonia. Emerg Infect Dis (2008) 1.04
Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn Microbiol Infect Dis (2005) 1.03
Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study. Clin Microbiol Infect (1998) 1.03
Therapeutic approaches to Chlamydia infections. Expert Opin Pharmacother (2005) 1.02
Waddlia chondrophila enters and multiplies within human macrophages. Microbes Infect (2008) 1.02
Lausannevirus seroprevalence among asymptomatic young adults. Intervirology (2013) 1.02
Waddlia chondrophila: from bovine abortion to human miscarriage. Clin Infect Dis (2011) 1.02
Outbreak of Mycobacterium haemophilum infections after permanent makeup of the eyebrows. Clin Infect Dis (2011) 1.01
Parachlamydia acanthamoebae enters and multiplies within pneumocytes and lung fibroblasts. Microbes Infect (2006) 1.01
Early intracellular trafficking of Waddlia chondrophila in human macrophages. Microbiology (2009) 1.01
Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients. Intensive Care Med (2009) 1.00
Free-living amoebae: Biological by-passes in water treatment. Int J Hyg Environ Health (2010) 1.00
Large-scale screening of a targeted Enterococcus faecalis mutant library identifies envelope fitness factors. PLoS One (2011) 1.00
Variations of plasmid content in Rickettsia felis. PLoS One (2008) 0.98
A simple blood-culture bacterial pellet preparation for faster accurate direct bacterial identification and antibiotic susceptibility testing with the VITEK 2 system. J Med Microbiol (2013) 0.98
Serological cross-reactivity between different Chlamydia-like organisms. J Clin Microbiol (2006) 0.97
Adult native septic arthritis: a review of 10 years of experience and lessons for empirical antibiotic therapy. J Antimicrob Chemother (2011) 0.97
Aspergillus species isolated from clinical specimens: suggested clinical and microbiological criteria to determine significance. Clin Microbiol Infect (1998) 0.96
Amoeba/amoebal symbiont genetic transfers: lessons from giant virus neighbours. Intervirology (2010) 0.96
Risk for Pneumocystis carinii transmission among patients with pneumonia: a molecular epidemiology study. Emerg Infect Dis (2003) 0.96
Tropheryma whipplei tricuspid endocarditis: a case report and review of the literature. J Med Case Rep (2010) 0.95
International Committee on Systematics of Prokaryotes. Subcommittee on the taxonomy of the Chlamydiae: minutes of the inaugural closed meeting, 21 March 2009, Little Rock, AR, USA. Int J Syst Evol Microbiol (2010) 0.95
Lateral gene exchanges shape the genomes of amoeba-resisting microorganisms. Front Cell Infect Microbiol (2012) 0.94
Resistance of different Chlamydia-like organisms to quinolones and mutations in the quinoline resistance-determining region of the DNA gyrase A- and topoisomerase-encoding genes. Int J Antimicrob Agents (2006) 0.93